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Abstract
To evaluate the role of human bocavirus (hBoV) as a causative agent of respiratory dis-
ease, the importance of the viral load in respiratory disease type and severity and the patho-
genicity of the different hBoV species, we studied all hBoV-positive nasopharyngeal
samples collected from children who attended an emergency room for a respiratory tract
infection during three winters (2009–2010, 2011–2012, and 2013–2014). Human bocavirus
was detected using the respiratory virus panel fast assay and real-time PCR. Of the 1,823
nasopharyngeal samples, 104 (5.7%) were positive for hBoV; a similar prevalence was
observed in all three periods studied. Among hBoV-infected children, 53.8% were between
1–2 years old, and hBoV was detected alone in 57/104 (54.8%) cases. All of the detected
hBoV strains belonged to genotype 1. The median hBoV load was significantly higher in
samples containing strains with both the N546H and T590S mutations compared to other
samples (p<0.05). Children with a single hBoV-1 infection more frequently had upper respi-
ratory tract infections (URTIs) than those who were co-infected (37.0% vs 17.8%, respec-
tively, p = 0.04). The duration of hospitalization was longer among children with high viral
loads than that observed among children with low viral loads (8.0 ±2.2 days vs 5.0 ±1.5
days, respectively, p = 0.03), and the use of aerosol therapy was more frequent among chil-
dren with high viral loads than among those with low viral loads (77.1% vs 55.7%, respec-
tively, p = 0.04). This study shows that hBoV is a relatively uncommon but stable infectious
agent in children and that hBoV1 seems to be the only strain detected in Italy in respiratory
samples. From a clinical point of view, hBoV1 seems to have in the majority of healthy chil-
dren relatively low clinical relevance. Moreover, the viral load influences only the duration of
hospitalization and the use of aerosol therapy without any association with the site of the
respiratory disease.
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Introduction
Human bocavirus (hBoV) is a recently identified viral agent that belongs to the family Parvo-
viridae and contains a single linear positive-sense or negative-sense single-stranded deoxyribo-
nucleic acid genome [1]. This virus has been detected mainly in younger children, in
nasopharyngeal secretions, in sera and blood samples of patients with upper (URTI) and lower
(LRTI) respiratory tract infections and in faecal specimens of subjects with gastroenteritis [2].
Currently, hBoVs are classified into species 1 through 4; hBoV1 is predominantly found in the
respiratory tract, and hBoV2, hBoV3, and hBoV4 are found mainly in stool [3].
Despite there are studies suggesting that hBoV is able to infect the lower airways causing
severe infections in both children and adults, the role of hBoV as a causative agent of respira-
tory disease is frequently questioned due to its common detection with other potential patho-
gens [4] and the evidence that in some studies co-infections can have a significantly greater
clinical and socioeconomic impact on infected children and their households than hBoV infec-
tion alone [5]. Moreover, the importance of the viral load in determining the type and severity
of respiratory disease as well as the pathogenicity of the different hBoV species [6] are not pre-
cisely defined. The main aim of this study was to contribute to resolving these problems. The
circulation of hBoV during several winter seasons in Italy was investigated, and a phylogenetic
analysis of detected strains was performed. In addition, correlations between different hBoV
strains and the severity of disease in cases with infections due to hBoV alone or due to co-infec-
tions were studied. Finally, the role of the viral load was analysed.
Methods
Study design
To evaluate the circulation of the different hBoV types and the possible relationships between
viral load, virus genetic characteristics, and the severity of infection, nasopharyngeal swabs
were collected from otherwise healthy children attending the emergency room of the Fonda-
zione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Italy, due to a
respiratory tract infection arising between November 1 and March 31 during 3 winters (2009–
2010, 2011–2012, and 2013–2014). The study was approved by the Ethics Committee of the
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy. Written informed
consent of a parent or legal guardian was required, and children 8 years of age were asked to
give their written assent. Patients’ demographic characteristics and medical histories were
retrieved from hospital charts and were systematically recorded before and after the first visit
to the emergency room using standardized written questionnaires [7]. The study patients were
classified into disease groups (i.e., acute otitis media, rhinosinusitis, pharyngitis, croup, infec-
tious wheezing, acute bronchitis, pneumonia) on the basis of signs and/or symptoms using
well-established criteria and were finally subdivided into two subgroups: upper (URTIs) and
lower respiratory tract infections (LRTIs) [8]. Nasopharyngeal secretions were collected from
all of the children immediately after admission to the emergency room using a paranasal
flocked swab (1 swab per child), which was stored in a tube containing 1 mL of universal trans-
port medium (Kit Cat. No. 360c, Copan Italia, Brescia, Italy).
Respiratory virus identification
Viral nucleic acids were extracted from each swab by means of a Nuclisens EasyMAG auto-
mated extraction system (Biomeriéux, Craponne, France), and the extract was tested for respi-
ratory viruses using the respiratory virus panel xTAG RVP FAST v2 (Luminex Molecular
Diagnostics, Inc., Toronto, Canada), which simultaneously detects influenza A virus (subtypes
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H1 or H3); influenza B virus; respiratory syncytial virus (RSV) types A and B; human parain-
fluenza virus types 1–4 (hPiV1-4); adenovirus (AdV); human metapneumovirus (hMPV);
coronaviruses (hCoV) 229E, NL63, OC43 and HKU1, enterovirus/rhinovirus (EV/hRV); and
hBoV, in accordance with the manufacturer’s instructions [9, 10]. Samples that were positive
for hBoV were stored at -80°C.
HBoV real-time polymerase chain reaction (PCR)
Viral nucleic acid extracts previously testing positive for hBoV were re-tested for confirmation
by two different singleplex real-time PCRs using TaqMan Universal Master Mix II (Applied
Biosystems, California, USA). Amplification and detection of viral DNA were performed with a
7900HT real-time PCR Systemmachine (Applied Biosystems, California, USA). Conserved
regions for RT-PCR primers and probes were identified in the hBoV NS-1 and NP-1 genes from
the nucleotide sequence alignments available from GenBank (for NS1, DQ206700-08,
DQ000495-96, and DQ200648, and for NP-1, DQ000495-96, AB243566-72, DQ296618-35,
DQ353695-99, DQ299885, DQ267760-75, DQ284856, DQ295844, and AM109958-66; http://
www.ncbi.nlm.nih.gov/genbank/). Each 25 μL singleplex reaction mixture consisted of 0.5 μL of
forward primer 5’-TGCAGACAACGCYTAGTTGTTT-3’ and reverse primer 5’-CTGTCCCG
CCCAAGATACA-3’ for the 88 base pair NS-1 target or forward primer 5’-
AGCATCGCTCCTACAAAAGAAAAG-3’ and reverse primer 5’-TCTTCATCACTTGGTCTGA
GGTCT-3’ for the NP-1 target, 0.125 μL of probe 5’-CCAGGATTGGGTGGAACCTGCAAA-3’
or 5’-AGGCTCGGGCTCATATCATCAGGAACA-3’, and 2.5 μL of sample viral DNA. PCRs
were conducted at 50°C for 2 min and then at 95°C for 10 min, followed by 45 cycles at 95°C for
15 sec and at 60°C for 1 min. TaqMan probes were labelled at the 5’ ends with the reporter mole-
cule 6-carboxyfluorescein and at the 3’ ends with Black Hole Quencher 1 (Biosearch Technolo-
gies, Inc., Novato, CA). Each run included one synthetic template control and one no-template
control for each target. Specimen extracts were also tested by real-time PCR for the human
RNase-P gene to monitor specimen quality and the presence of PCR inhibitors. A positive test
for both the NS1 and NP-1 targets or for a single target confirmed from a second extraction
from a new sample aliquot was considered definitive evidence of hBoV infection.
The viral load was obtained using real-time PCR with the NS1 primers and probe previously
described and a DNA plasmid used as the standard calibrator. The amplified target fragment
of the plasmid was verified by sequencing. Plasmid DNA concentrations were detected with an
ND-1000 spectrophotometer (NanoDrop products, Wilmington, DE, USA). Each run included
plasmid and negative controls. Standard precautions were taken throughout the PCR process
to avoid cross-contamination. Negative controls and serial dilutions of the positive controls
were included in every PCR assay. Finally, quantitative results were reported as DNA copies/
mL of respiratory samples. The viral load was defined as low for values106 log (copies/mL)
and as high for values>106 log (copies/mL).
HBoV sequencing
For genotyping, the viral VP-1/2 gene was amplified using a conventional PCR assay. Briefly, 4
sets of forward and reverse primers (5’-CACAGACAGAAGCAGACGAGAT-3’ and 5’-GGTG
AGAAGTGACAGCTGTATTG-3’; 5’-TTCAGAATGGTCACCTCTACA-3’ and 5’-CTGTGC
TTCCGTTTTGTCTTA-3’; 5’-AACTTTGACTGTGAATGGGTTA-3’ and 5’-AAATAGTGCC
TGGAGGATGAT-3’; 5’-CTATCACCAGAGAAAATCCAATC-3’ and 5’-GAGACGGTAACA
CCACTA-3’) were used in PCR amplification and the Quantitect Probe Master Mix (QIA-
GEN, Venlo, Netherlands) was used as the basis for the reaction mix. Viral products were ana-
lysed by electrophoresis on a 1.5% agarose gel and purified with the QIAquick Gel Extraction
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Kit (QIAGEN, Venlo, Netherlands). Sequencing reactions were set up with purified DNA, one
of the specific primers used in the PCR and BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems, California, USA) according to the protocol recommended by the manu-
facturer. Sequencing and sequence analysis were performed on a 3130 Genetic Analyser
(Applied Biosystems, California, USA).
Sequence analysis
All alignments were performed using ClustalX 2.1 and BioEdit (version 7.1.3.0) software (Ibis
Biosciences, Carlsbad, CA). Phylogenetic trees of the VP-1/2 protein gene were generated
using the neighbour-joining method and p-distance model of the Molecular Evolutionary
Genetics Analyses (MEGA) software, version 5.05 [11]. Bootstrap probabilities for 1,000 itera-
tions were calculated to evaluate confidence estimates. The graphs were made using GraphPad
Prism version 5.01 for Windows (GraphPAD Software, San Diego, CA). All genotyped
sequences of the hBoV VP-1/2 gene were submitted to GenBank (accession numbers
KR014412-KR014516).
Selective pressure analyses
Tests for positive selection were conducted on the Datamonkey server [12] using the single-
likelihood ancestor (SLAC), and the fixed-effects likelihood (FEL) [13], the internal branch
fixed-effects likelihood (IFEL) [14], the mixed effects model of evolution (MEME) [15], and
fast unconstrained Bayesian approximation methods (FUBAR). The dN/dS ratios were calcu-
lated using the SLAC and FEL codon-based maximum likelihood approaches. The SLAC
approach counts the number of non-synonymous changes per non-synonymous site (dN) and
tests whether it is significantly different from the number of synonymous changes per synony-
mous site (dS). The FEL approach estimates the ratios of non-synonymous to synonymous
changes for each site in an alignment. The IFEL method is similar to the FEL, but tests site-by-
site selection along only the internal branches of the phylogeny. In order to avoid an excessive
false-positive rate, sites with SLAC, FEL, IFEL and MEME p-values of<0.1 and a FUBAR pos-
terior probability of>0.90 were accepted as candidates for selection.
Statistical analysis
Descriptive statistics of the responses were generated. Continuous variables were presented as
mean values and standard deviations (SDs) and categorical variables as numbers and percent-
ages. For categorical data, comparisons between groups were performed using a contingency
table analysis with the Χ2 or Fisher’s exact test when appropriate. For ordered categorical data,
a Cochran-Armitage test for trend was used to compare the groups. Continuous data were ana-
lysed using a two-sided Student’s t-test after ensuring the data were normally distributed
(based on the Shapiro-Wilk statistic) or using a two-sided Wilcoxon’s rank-sum test if the data
were non-normal. All analyses were two tailed, and p-values of 0.05 or less were considered to
be statistically significant. All analyses were conducted using SAS version 9.2 (Cary, NC, USA).
Results
HBoV incidence and genotypes
During the three study periods, 1,823 nasopharyngeal samples were collected in the emergency
room. Of these, 104 (5.7%) tested positive for hBoV (Table 1). Among hBoV infected children,
53.8% were between 1–2 years old, whereas 28.8% and 17.3% were aged<1 and3 years,
respectively. The prevalence of hBoV detection was quite similar in the three studied periods;
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30 (28.6%), 39 (37.1%), and 36 (34.3%) positive samples were collected in the winter seasons of
2009–2010, 2011–2012, and 2013–2014, respectively. HBoV was the only virus detected in 57/
104 (54.8%) cases and was detected in association with one (89.5%) or more (10.5%) viruses in
47 (45.2%) cases. EV/hRV and RSV were the most common co-infecting viral agents and were
found, respectively, in 20 and 18 samples. Subjects with co-infection were younger than those
without (p = 0.03). Considering 106 DNA copies/mL as a cut-off, the viral load was classified as
low in 66 (63.5%) cases and as high in 38 (36.5%) cases.
Phylogenetic analyses and amino acid signatures
The phylogenetic tree constructed using the VP1/VP2 sequences showed that all of the Italian
hBoV strains detected during the three study periods belonged to hBoV genotype 1 (Fig 1). No
unusual clustering was observed among the identified strains; hBoVs circulating in 2009 were
closely related to strains circulating in 2014. The sequence identity matrix of the VP1/VP2
gene showed minimum to maximum identity ranges of 97.8–100% between the Italian strains
and 98.4–99.7% with respect to hBoV st1 reference strains (DQ000495). In comparison to the
reference strain, 8/105 (7.6%) strains had only one amino acid difference, 32/105 (30.4%)
strains had two amino acid differences, and the remaining strains (65/105; 61.9%) had at least
three amino acid changes.
A total of 61/672 (9.1%) amino acid positions were observed to have at least one change in
the VP1/VP2 sequence alignments (Fig 2). Of these, 7/61 (11.5%) changes occurred within the
VP1 unique (VP1U) region corresponding to the first 129 amino acids at the N-terminus of
the VP1 gene. Specifically, the following changes were observed: R17K, G28D, E29K, L40S,
H43Q, D72N, and G126E (Fig 2).
The VP1U region includes the conserved phospholipase A2 (PLA2) motif (nt 21–63). The
VP1U sequences of all hBoV isolates identified in this study revealed conserved YXGXG (nt
16–20) and HDXXY (nt 41–45) motifs in the catalytic site of secreted PLA2. In addition, the
amino acid residues at positions 21, 41, 42 and 63 have been hypothesized to form the catalytic
network for enzymatic activity. In our hBoV strains, all the sequences had amino acids associ-
ated with efficient enzymatic activity (P21, H41, D42, and D63).
Of note, two hBoV strains (MI-267-Jan2014 and MI-272-Jan2014) had a peculiar amino acid
sequence in the 19-amino acid segment starting at amino acid 411 (KVPTRRVQPYIRQTNWKHR),
which has not been previously reported in hBoV strains included in the GenBank database (in
red, Fig 1). Overall, these two strains had 13 and 14 amino acid changes compared to the hBoV
Table 1. Positivity for bocavirus in children with respiratory tract infections, according to age group and presence of co-infection(s).
No. (%) of positive samples
Age group (years) Overall Without co-infection With co-infection(s) Low viral load High viral load
< 1 30 (28.8) 12 (21.0) 18 (38.3) 22 (33.3) 8 (21.0)
1–2 56 (53.8) 32 (56.1) 24 (51.1) 31 (47.0) 25 (65.8)
 3 18 (17.3) 13 (22.8) 5 (10.6) 13 (19.7) 5 (13.2)
Total 104 57 47 66 38
One missing value for age.
Viral load was categorized in two groups, and was considered “low” for values 6 log (copies/mL) and “high” for values >6 log (copies/mL).
p-value = 0.03 for comparison between subgroups of presence of co-infection(s), according to age group (Cochran-Armitage trend test).
p-value = 0.67 for comparison between subgroups of viral load, according to age group (Cochran-Armitage trend test).
doi:10.1371/journal.pone.0135640.t001
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st1 strain, and almost all these changes were included in the region described below. The origin
of this highly divergent region, which occurred in spite of the conservation displayed in the rest
of the hBoV DNA genome, remains to be defined.
Selective pressure
A global analysis of selective pressure made using the SLAC model indicated an estimated
overall dN/dS ratio of 0.18. Overall, the site-specific analyses identified three sites (411, 536,
and 546) as under positive selection by at least two methods used (SLAC, FEL, FUBAR, and
MEME). The IFEL model was used to determine the selection pressure acting on the VP1/VP2
codons along the internal branches of the tree. Two positively selected codons (411 and 546)
were identified. The selected sites, highlighted with arrows in Fig 2, were presumably located in
Fig 1. Phylogenetic tree based on complete VP1/VP2 gene sequences of human bocavirus (hBoV) strains. Sequences originating from this study are
indicated with black and red circles. HBoV reference stains are in bold. The percentage of replicate trees in which the associated taxa clustered together in
the bootstrap test (1,000 replicates) are shown next to the branches.
doi:10.1371/journal.pone.0135640.g001
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Fig 2. Alignment of VP1/VP2 amino acid changes with respect to the prototype strain (human bocavirus [hBoV] st1; DQ000495) in 105 Italian hBoV
strains.Dots indicate identity. Amino acids highlighted in bold are under positive selective pressure. The bar length corresponds to the viral load levels. The
viral load levels of strains with the T590S change and an additional change in a codon under positive selection are marked with an asterisk.
doi:10.1371/journal.pone.0135640.g002
Table 2. Positively and negatively selected sites for human bocavirus strains originating from this
study.
Method Positive Negative
SLAC None 29 sites
FEL 536, 546 34 sites
FUBAR 17, 40, 225, 361, 411, 421, 534, 535, 536, 546, 563 38 sites
IFEL 411, 546 17 sites
MEME 225, 361, 392, 396, 401, 409, 410, 411, 413, 421, 428, 546, 547, 556, 563 -
FEL: ﬁxed-effects likelihood; FUBAR: fast unconstrained Bayesian approximation methods; IFEL: internal
branch ﬁxed-effects likelihood; MEME: mixed effects model of evolution; SLAC: single-likelihood ancestor.
doi:10.1371/journal.pone.0135640.t002
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the external loop of the VP1 or VP2 protein. In detail, the Ala (A) to Ser (S) mutation was
observed at codon 411 and occurred in 7 hBoV strains circulating in January 2012, the Ala (A)
to Thr (T) mutation was observed in one strain circulating in December 2013, and the Ala (A)
to Lys (K) mutation was observed in two strains circulating in January 2014. The Val (V) to
Asp (D) mutation at codon 536 was observed in 8 hBoV strains circulating in the 2009–11 and
2013 seasons which were associated with N534K and Q535P mutations. Finally, the Asn (N) to
His (H) mutation at codon 546 occurred in 13 hBoV strains circulating in the 2009–2012 sea-
sons. Of these strains, 6/13 (46.1%) were also characterized by the N534K, Q535P, and Q535D
mutations. Several negatively selected sites were identified by different methods (Table 2).
Mutations and viral load
Regarding the viral load, a wide range of hBoV DNA levels from 3.5x102 to 7.5x109 copies/mL
were found in the clinical samples. In Fig 2 (right side), the viral load of each Italian hBoV strain
is reported near the aligned mutations. In the group of strains (n = 70; 66.6%) harbouring at
least 2 mutations in addition to A149T, the values of the hBoV load greater than 1x108 DNA
copies/ml are reported in grey. A total of 16 strains had a very high viral load, and 13/16
(81.3%) harboured the T590S mutation. This percentage is nearly significantly different than
the overall frequency (42/70; 53.8%) of T590S in the group of strains described below (p = 0.08).
Seven of the 13 strains with the T590S mutation had an additional mutation in one of the sites
under positive selection (reported in Fig 2 with an asterisk). In detail, 4/13 (30.8%) had the
N546H change, 2/13 (15.4%) had the A411D change, and 1/13 (7.7%) had the A411T change.
Based on the observed data, we hypothesize that the double mutation of N546H with T590S
may positively affect viral replication and specific immune response. As shown in Table 3, the
median hBoV load was significantly higher in samples of strains with the N546H and T590S
changes than that in samples of wild type T590 strains, strains with only the T590S mutation,
and strains with only the N546Hmutation (p-values of 0.0078, 0.016 and 0.018, respectively).
Finally, the two divergent strains (MI-267-Jan2014 andMI272-Jan2014) with unusual amino
acid changes were observed with viral loads lower than 106 DNA copies/mL. This could suggest
that these mutations do not confer a replicative advantage in these virus strains.
Clinical characteristics of hBoV1 infection
In Table 4, data regarding demographic, clinical and laboratory characteristics of children
infected by hBoV-1 alone or co-infected with hBoV-1 and one or more other respiratory
Table 3. Presence of mutations in human bocavirus strains and relation of mutations with viral load.
Groups No. Viral load (DNA copies/mL P value
Median Range
A. Strains with T590 36 4.6 x 104 3.5 x 102–5.9 x 108
B. Strains with only T590S 61 4.5 x 104 5.8 x 102–7.5 x 109
C. Strains with only N546H 5 2.2 x 103 3.5 x 102–5.9 x 108
D. Strains with N546H+T590S 8 1.1 x 109 1.6 x 104–2.8 x 109
A vs B 0.31
A vs C 0.33
A vs D 0.0078
B vs C 0.17
B vs D 0.016
C vs D 0.018
doi:10.1371/journal.pone.0135640.t003
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viruses are reported. Because a preliminary evaluation did not find any differences among sub-
jects co-infected with EV/HRV, RSV or other viruses, all co-infections were considered
together. As shown, children infected with only hBoV-1 had URTIs more frequently than
those with a co-infection (37.0% vs 17.8%, respectively, p = 0.04). Moreover, a similar illness
within the family in the 7 days since patient enrolment was significantly more common among
co-infected children than among those with a single infection (48.9% vs 26.5%, respectively,
p = 0.02). No other significant differences between the groups were observed.
Table 5 shows the demographic, clinical, and laboratory characteristics of the enrolled sub-
jects according to the hBoV load. Subjects with low and high viral loads were quite similar. The
only significant differences were found in the duration of hospitalization, which was longer
among children with a high viral load than among those with a low viral load (8.0 ±2.2 days vs
5.0 ±1.5 days, respectively, p = 0.03), and in the use of aerosol therapy, which was more fre-
quent among children with a high viral load than among those with a low viral load (77.1% vs
55.7%, respectively, p = 0.04). Moreover, mutations leading to a high or low viral load were not
associated with atypical clinical characteristics.
Discussion
This study shows that in Italy during the winter periods 2009–2010, 2011–2012, and 2013–
2014, the incidence of hBoV infection among children with respiratory disease was relatively
low, limited to approximately 5% of cases, and did not significantly vary from year to year.
The phylogenetic analysis showed that all of the strains detected in this study belonged to
hBoV genotype 1 and were closely related to the prototype strain identified by Allander et al.
[1]. This was expected because this genotype is the most common among hBoVs associated
with respiratory infections [1].
Most of the patients in whom hBoV1 was identified were younger than 3 years of age, fur-
ther highlighting that younger children are the individuals most frequently infected by this
viral agent [1]. Serological studies have shown evidence that the number of subjects positive for
anti-hBoV1 antibodies continuously increases with increasing age group from the ages of 6
months to 6 years, and by the age of 2 years approximately 80% of children have been infected
with hBoV1 [16,17]. More than 50% of the children infected by hBoV1 in this study were co-
infected with at least one other respiratory virus. Moreover, co-infected patients had LRTI
more frequently than those infected by hBoV alone. These findings are not surprising because
simultaneous detection of hBoV1 and other viruses in children with respiratory disease and
greater severity in co-infected cases have been already reported in studies in which it was also
demonstrated that hBoV1 can frequently be identified in the respiratory secretions of asymp-
tomatic subjects [18–23]. Recently, it has been reported that hBoV1 can be shed for several
days or months after a previous infection [24], which could explain the simultaneous identifi-
cation of hBoV1 and other respiratory viruses, the frequency of asymptomatic infections and
the generally greater severity of infections in co-infected individuals compared to those with
hBoV1 alone. In most of the co-infected cases, detection of hBoV in the respiratory secretions
with the new sensitive molecular methods able to identify very low viral loads might be a conse-
quence of a previous clinically resolved disease, and a virus other than hBoV was therefore the
real cause of the disease. However, reports of severe clinical manifestations in patients infected
with only hBoV have been published [25], highlighting that the assessment of the real impor-
tance of hBoV infection in a single patient remains very difficult. Studies on children with
severe pneumonia, acute wheezing, asthma and/or bronchiolitis suggested that hBoV1 is able
to infect the lower airways down to the bronchioles [26–32]. Moreover, hBoV1 has been found
as the only infectious agent in adult lung transplant recipients with severe LRTI, whereas it was
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not detected in respiratory secretions of asymptomatic transplanted subjects [33]. This would
indicate that hBoV1 is not always a bystander or the cause of mild respiratory problems but
rather a real, although relatively rare, causative agent of severe disease in both children and
adults, particularly when they are immunocompromised. On the other hand, hBoV can cause
serious neurological infections [34] and contribute to chronic disease in adult patients mainly
because it can persist after childhood infection and reactivate [35].
Table 4. Comparisons between subjects positive for human bocavirus with or without co-infection(s), according to demographic, clinical and lab-
oratory variables.a
Characteristic Without co-infection(s) N = 57 With co-infection(s) N = 48 P value for comparison
n/N (%) n/N (%)
Demographic and clinical presentation
Males (%) 28/54 (51.8) 30/48 (62.5) 0.28
Mean age ± SD, yrs 2.30 ± 2.24 1.63 ± 1.31 0.06
Presence of fever” (%) 47/48 (97.9) 43/45 (95.6) 0.61
High-grade fever° (%) 24/48 (50.0) 25/45 (55.6) 0.59
Respiratory rate, breaths/min 34.7 ± 8.0 37.7 ± 10.3 0.66
SpO2 in room air, mean % ± SD 98.0 ± 1.7 96.8 ± 2.4 0.06
Clinical ﬁndings
Cough 41/49 (83.7) 39/47 (83.0) 0.93
Rhonchi 2/49 (4.1) 4/47 (8.5) 0.43
Rales 15/49 (30.6) 15/47 (31.9) 0.89
Wheezes 7/49 (14.3) 9/47 (19.1) 0.52
Upper respiratory tract infection 17/46 (37.0) 8/45 (17.8) 0.04
Lower respiratory tract infection 25/55 (45.4) 24/46 (52.2) 0.50
Clinical outcome
Hospitalisation rate, no.(%) 7/49 (14.3) 10/47 (21.3) 0.37
Duration of hospitalisation, mean days ± SD 7.4 ± 2.6 5.9 ± 2.2 0.35
Drug use, no. (%)
Antibiotics 38/49 (77.5) 40/47 (85.1) 0.34
Antipyretics 42/49 (85.7) 39/47 (83.0) 0.71
Aerosol therapy 29/49 (59.2) 32/47 (68.1) 0.36
Absence from community, mean days ± SD 7.9 ± 5.0 9.2 ± 7.0 0.84
Similar illness within the family 13/49 (26.5) 23/47 (48.9) 0.02
Laboratory data
White blood cell count (cells/μL) 15,319 ± 6,805 11,889 ± 3,680 0.27
Neutrophils, % 49.2 ± 28.4 38.5 ± 24.7 0.42
Lymphocytes, %b 26.3 ± 17.4 31.6 ± 4.6 0.99
Monocytes, %b 9.4 ± 4.6 11.2 ± 0.4 0.46
Basophils, %b 0.4 ± 0.3 0.2 ± 0.0 0.65
Eosinophils, %b 0.7 ± 0.6 0.6 ± 0.8 0.88
CRP, μg/dL 6.2 ± 15.4 1.4 ± 2.2 0.32
CRP: C reactive protein; SD: standard deviation; SpO2: peripheral oxygen saturation.”38.0°C or more any time during the illness (before or at enrolment,
or during follow-up); °39.0°C or more any time during the illness (before or at enrolment, or during follow-up).
aData were extracted from datasets of different studies that collected different information, therefore the denominators vary across characteristics.
bInformation available for 9 subjects only (7 without co-infection and 2 with co-infection).
doi:10.1371/journal.pone.0135640.t004
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Evaluation of the viral load has been considered a possible method to define when this virus
is the real cause of a respiratory disease and when it is only a secondary infection. Unfortu-
nately, this approach has had no success because although some studies have shown evidence
for a strict correlation between high viral load and severe LRTI in children with a single hBoV
Table 5. Comparison between subjects with low and high viral human bocavirus loads, according to demographic, clinical and laboratory
variables.a
Characteristic Low viral load (106 hBoV DNA copies/
mL) N = 67
High viral load (>106 hBoV DNA copies/
mL) N = 38
P value for
comparison
n/N (%) n/N (%)
Demographic and clinical
presentation
Males (%) 40/64 (62.5) 18/38 (47.4) 0.14
Mean age ± SD, yrs 2.00 ± 2.04 1.98 ± 1.66 0.55
Presence of fever” (%) 58/58 (100.0) 32/35 (91.4) 0.05
High-grade fever° (%) 31/58 (53.5) 18/35 (51.4) 0.85
Respiratory rate, breaths/min 36.8 ± 8.6 36.6 ± 11.1 0.73
SpO2 in room air, mean % ± SD 97.3 ± 2.3 97.0 ± 2.1 0.49
Clinical ﬁndings
Cough 48/61 (78.7) 32/35 (91.4) 0.11
Rhonchi 4/61 (6.6) 2/35 (5.7) 0.99
Rales 19/61 (31.1) 11/35 (31.4) 0.98
Wheezes 11/61 (18.0) 5/35 (14.3) 0.64
Upper respiratory tract infection 18/57 (31.6) 7/34 (20.6) 0.26
Lower respiratory tract infection 32/64 (50.0) 17/37 (46.0) 0.69
Clinical outcome
Hospitalisation rate, no.(%) 10/61 (16.4) 7/35 (20.0) 0.66
Duration of hospitalisation, mean
days ± SD
5.0 ± 1.5 8.0 ± 2.2 0.03
Drug use, no. (%)
Antibiotics 51/61 (83.6) 27/35 (77.1) 0.43
Antipyretics 52/61 (85.2) 29/35 (82.9) 0.76
Aerosol therapy 34/61 (55.7) 27/35 (77.1) 0.04
Absence from community, mean
days ± SD
8.6 ± 6.3 8.2 ± 5.5 0.88
Similar illness within the family 22/61 (36.1) 14/35 (40.0) 0.70
Laboratory data
White blood cell count (cells/μL) 13,191 ± 6,847 14,727 ± 4,337 0.28
Neutrophils, % 41.9 ± 24.2 50.2 ± 32.1 0.52
Lymphocytes, %b 31.7 ± 13.1 19.1 ± 19.0 0.39
Monocytes, %b 11.7 ± 2.7 5.9 ± 3.6 0.09
Basophils, %b 0.4 ± 0.3 0.3 ± 0.4 0.90
Eosinophils, %b 0.7 ± 0.7 0.6 ± 0.5 0.99
CRP, μg/dL 5.5 ± 14.6 1.6 ± 1.8 0.94
CRP: C reactive protein; SD: standard deviation; SpO2: peripheral oxygen saturation.”38.0°C or more any time during the illness (before or at enrolment,
or during follow-up); °39.0°C or more any time during the illness (before or at enrolment, or during follow-up).
aData were extracted from datasets of different studies that collected different information, therefore the denominators vary across characteristics
bInformation available for 9 subjects only (6 with low and 3 with high viral load).
doi:10.1371/journal.pone.0135640.t005
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infection [36–38], others, including the present study, did not show a clear relationship
between these two variables [39].
However, the evolution of virulence appears to involve a variety of mechanisms in different
viral systems, including mutations in regulatory regions and viral adaptation for utilization of
alternative or expanded repertoires of cellular receptors. An alternative hypothesis to evaluate
the importance of hBoV1 concerns the correlation between viral load levels and the presence of
specific mutations. However, mutations associated with increased or reduced replication are
rarely reported for hBoV. Recently, Hao et al. have reported that few nucleotide changes were
correlated with a lower viral load [40]. In the present study, a double mutant (N546H and
T590S) was observed in samples with a significantly higher viral load. However, further pheno-
typic validation studies are required to draw major conclusions regarding the impact of these
mutations on viral replication. Furthermore, as reported by Qu et al. [41], it seems that nucleo-
tide changes in the VP1U region could affect the replication efficiency of hBoV. Likewise, in
our strains all the amino acids of the catalytic site were conserved, and no mutations that affect
sPLA2 activity were identified.
In agreement with others [42], the phylogenetic analysis of this study confirmed the very
low degree of variability in the hBoV genomic region encoding proteins that are exposed to the
virus surface and are therefore under immunologic pressure. Only 9% (62 codons) of amino
acids were found to have at least one change in the VP1/VP2 gene, a finding not substantially
different from that reported by Hao et al. in a different geographic area [40]. In our study, sev-
eral amino acid changes were observed in strains circulating in almost all the respiratory sea-
sons. This finding provides evidence that the selection of those variants best adapted to each
particular environment might select for variants with an evolutionary advantage. Seven of
these mutations were located in a genomic region (i.e., VP1U) previously reported to be
involved in the mechanisms of virus replication. For instance, the VP1U amino acid variations
R17K and L40S have been previously reported [43], whereas the remaining variations have not
yet been described. Interestingly, two hBoV strains identified in respiratory samples collected
in January 2014 had unusual amino acid sequences in a somewhat conserved genomic region.
The reason for this genetic diversity is still undefined. However, as described for hBoV, other
parvoviruses [44], and enteroviruses, a series of α-helices and β-barrels in the VP2 protein
were intercalated by an external loop, in which the majority of the genetic variability accumu-
lated. Nevertheless, these two divergent strains were found in samples with low viral loads, and
we might hypothesize a loss of replication advantage for these strains.
In the present study, the dN/dS ratios for all pairwise comparisons were<1, which is in line
with previous results showing that positive selection was extremely limited in parvoviruses
[45]. In fact, selective pressure analyses have identified 3 codons under positive selection. In a
previous paper, a different codon (L40) was identified as being under positive selection [46].
Nevertheless, the great majority of codons were under negative or neutral selection, which has
also been confirmed by others [47]. This finding suggests that only a few amino acids of the
VP1/VP2 proteins present on the surface of the virion are potentially subjected to a strong
selective pressure by the host immune response.
In conclusion, this study confirms that hBoV is less common than other respiratory viruses
but that the frequency of its detection in children with respiratory disease is in time stable. It
was detected with a prevalence of about 5% in several consecutive seasons and no unusual clus-
tering was observed among identified strains, with strains circulating in 2009 being closely
related to those circulating in 2014. Moreover, only a minority of virus sites were found to be
under positive selective pressure, and all the strains detected in respiratory tract infections of
this Italian study belonged to genotype 1. From a clinical point of view, this study highlights
that in otherwise healthy children, hBoV1 seems to have relatively low clinical relevance,
Bocavirus Circulation in Children
PLOS ONE | DOI:10.1371/journal.pone.0135640 August 12, 2015 12 / 15
because patients infected with hBoV alone mainly suffered from an URTI. The viral load was
not associated with clinical characteristics of the infection, and viral mutations, despite affect-
ing viral replication, did not affect the conditions or severity of the clinical presentation. Fur-
ther studies are needed to clarify the clinical relevance of hBoV in children, particularly in
those at risk for severe chronic underlying disease, and to evaluate the role of viral modification
in conditioning the degree of viral virulence and the specific immune response.
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